Feed SCYX
SC

SCYNEXIS, Inc.

SCYX · NASDAQ

$3.96 -2.59% (-$0.10)
1M +11.78%
Market Cap $24.9M
P/E Ratio -
Div. Yield -
ROE 19.94%

Bulios Fair Price

$135.54

3327.1% upside

Current Price

$3.96

Undervalued Fair Value Overvalued
Valuation
88 /100
Cheap
P/B 0.50x
P/S 1.21x
EV/EBITDA N/A
Growth
100 /100
Growing
Book val. growth 148.11%
Rev. growth 59.35%
FCF growth N/A
Profitability
20 /100
Weak
Net margin 0.00%
Op. margin 0.00%
FCF margin 0.00%
Quality
3 /100
Poor
ROE 0.00%
ROA 0.00%
Asset turnover 0.35x
Debt
56 /100
Moderate
Current ratio 7.04x
Int. coverage -48.76x
Net debt/EBITDA 2.26x
Stability
13 /100
Unstable
Rev. volatility 1,455.71%
EPS volatility 164.02%
Profitable years 0
Ask StockBot about SCYX
Online

Sector

Healthcare

Industry

Medical - Pharmaceuticals

CEO

David Angulo

Employees

18

Headquarters

Jersey City

Upcoming events

12 AUG

Earnings

Upcoming earnings report

20d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.